Stock Analysis

Three Stocks Investors May Be Undervaluing Based On Current Market Estimates

SHSE:688351
Source: Shutterstock

In the midst of global market fluctuations, with U.S. stocks ending lower due to tariff uncertainties and mixed economic signals from major regions like Europe and Japan, investors are keenly observing potential opportunities in undervalued stocks. As the market grapples with these challenges, identifying stocks that may be trading below their intrinsic value can provide a strategic edge for those looking to capitalize on current conditions.

Top 10 Undervalued Stocks Based On Cash Flows

NameCurrent PriceFair Value (Est)Discount (Est)
Gilead Sciences (NasdaqGS:GILD)US$96.14US$191.7449.9%
National World (LSE:NWOR)£0.227£0.4549.5%
On the Beach Group (LSE:OTB)£2.495£4.9449.5%
TCI (TPEX:8436)NT$119.00NT$237.0049.8%
Hanjaya Mandala Sampoerna (IDX:HMSP)IDR575.00IDR1141.1049.6%
APAC Realty (SGX:CLN)SGD0.455SGD0.9149.9%
Smurfit Westrock (NYSE:SW)US$53.64US$107.0449.9%
Array Technologies (NasdaqGM:ARRY)US$6.87US$13.6649.7%
SK D&D (KOSE:A210980)₩7110.00₩14097.0749.6%
Pantoro (ASX:PNR)A$0.135A$0.2749.5%

Click here to see the full list of 899 stocks from our Undervalued Stocks Based On Cash Flows screener.

Here's a peek at a few of the choices from the screener.

Shanghai MicroPort EP MedTech (SHSE:688351)

Overview: Shanghai MicroPort EP MedTech Co., Ltd. focuses on the research, development, production, and sale of medical devices for electrophysiological interventional diagnosis and ablation therapy both in China and internationally, with a market cap of CN¥9.02 billion.

Operations: The company's revenue is primarily derived from its Surgical & Medical Equipment segment, amounting to CN¥383.99 million.

Estimated Discount To Fair Value: 16.3%

Shanghai MicroPort EP MedTech is trading at CN¥19.16, below its estimated fair value of CN¥22.89, suggesting undervaluation based on cash flows. Despite a low forecasted ROE of 5.6%, the company's earnings are expected to grow significantly at 54.5% annually over the next three years, outpacing the Chinese market's growth rate. Recent regulatory approvals for innovative products like the Magbot Catheter and Genesis RMN System bolster its potential revenue growth and market position in China’s medical device sector.

SHSE:688351 Discounted Cash Flow as at Feb 2025
SHSE:688351 Discounted Cash Flow as at Feb 2025

Temenos (SWX:TEMN)

Overview: Temenos AG develops, markets, and sells integrated banking software systems to banking and other financial institutions worldwide, with a market cap of CHF5.78 billion.

Operations: The company's revenue segments include software licensing, which generated $347.5 million, software-as-a-service with $164.3 million, maintenance at $444.8 million, and services contributing $125.6 million.

Estimated Discount To Fair Value: 19.6%

Temenos, trading at CHF79.25, is undervalued compared to its estimated fair value of CHF98.61. The company's revenue is projected to grow at 7.3% annually, surpassing the Swiss market's 4.3%. Recent client wins with Aldermore Bank and CEC Bank highlight its strong SaaS offerings and cloud-based solutions, enhancing operational efficiency and customer experience. Despite a high debt level, Temenos' earnings are expected to grow faster than the Swiss average at 12% per year.

SWX:TEMN Discounted Cash Flow as at Feb 2025
SWX:TEMN Discounted Cash Flow as at Feb 2025

Advantage Energy (TSX:AAV)

Overview: Advantage Energy Ltd. operates in the acquisition, exploitation, development, and production of natural gas, crude oil, and natural gas liquids in Alberta, Canada with a market cap of CA$1.58 billion.

Operations: The company's revenue segment includes CA$488.84 million from Advantage Oil & Gas Ltd.

Estimated Discount To Fair Value: 48.3%

Advantage Energy, priced at CA$9.68, trades significantly below its fair value of CA$18.72. Despite a high debt level, its earnings are forecast to grow substantially at 45% annually over the next three years, outpacing the Canadian market's growth rate of 17.1%. Revenue is also set to increase by 21.1% per year, exceeding the market average of 5.8%, although profit margins have decreased from last year’s levels.

TSX:AAV Discounted Cash Flow as at Feb 2025
TSX:AAV Discounted Cash Flow as at Feb 2025

Make It Happen

Ready To Venture Into Other Investment Styles?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About SHSE:688351

Shanghai MicroPort EP MedTech

Engages in the research, development, production, and sale of medical devices in the field of electrophysiological interventional diagnosis and ablation therapy in China and internationally.

Flawless balance sheet with high growth potential.

Community Narratives

Priced for AI perfection - cracks are emerging
Fair Value US$90.15|47.31% overvalued
ChadWisperer
ChadWisperer
Community Contributor
NVDA Market Outlook
Fair Value US$341.12|61.068999999999996% undervalued
NateF
NateF
Community Contributor
Karoon Energy (ASX:KAR) - Buy Baby Buy 🚀
Fair Value AU$5.10|70.392% undervalued
StockMan
StockMan
Community Contributor